We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure 1

Figure 1. From: Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment.

Time course of mean HbA1c in patients with severe renal impairment receiving insulin therapy.
Notes: Mean ± standard error. n for vildagliptin group at baseline and week 24 = 99 and 81 patients, respectively; n for placebo group at baseline and week 24 = 77 and 59, respectively.

Valentina Lukashevich, et al. Vasc Health Risk Manag. 2013;9:21-28.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk